Cargando…
The Early Diagnosis of Alzheimer’s Disease: A Patient-Centred Conversation with the Care Team
Alzheimer’s disease (AD) is a neurodegenerative disorder which accounts for 60–80% of dementia cases, affecting approximately 10 million people in Europe. Neuroimaging techniques and cerebrospinal fluid biomarkers used in combination with cognitive assessment tools open the door to early diagnosis o...
Autores principales: | Nasreddine, Ziad, Garibotto, Valentina, Kyaga, Simon, Padovani, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837364/ https://www.ncbi.nlm.nih.gov/pubmed/36528836 http://dx.doi.org/10.1007/s40120-022-00428-7 |
Ejemplares similares
-
The Usefulness of Biological and Neuroimaging Markers for the Diagnosis of Early-Onset Alzheimer's Disease
por: Padovani, Alessandro, et al.
Publicado: (2011) -
Viewing the Brain Through Retina: A New Avenue for Early Diagnosis of Alzheimer’s Disease
por: Zuhair, Varisha, et al.
Publicado: (2023) -
Examination of a non-invasive biomarker for the diagnosis of prodromal Alzheimer's disease and Alzheimer's disease Dementia
por: Dupree, Emmalyn J., et al.
Publicado: (2020) -
Cost and Return on Investment of a Team-Based Palliative Care Program for Parkinson Disease
por: McQueen, Robert Brett, et al.
Publicado: (2022) -
Sustaining primary care teams in the midst of a pandemic
por: Sullivan, Erin E., et al.
Publicado: (2020)